# Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

> **NCT07045142** · PHASE3 · RECRUITING · sponsor: **Central South University** · enrollment: 400 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07045142
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-06-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07045142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07045142, "Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07045142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*